Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants

Transplantation

Volumn 73, Issue 5, 2002, Pages 679-688

  Orloff, Susan L ^a,b,e   Streblow, Daniel N ^b   Soderberg Naucler, Cecilia ^c   Yin, Qiang ^a,b   Kreklywich, Craig ^b   Corless, Christopher L ^a,b   Smith, Patricia A ^b   Loomis, Christopher B ^a   Mills, Lisa K ^a   Cook, Judith W ^b   Bruggeman, Catherine A ^d   Nelson, Jay A ^b   Wagner, Cynthia R ^a,e  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CHIMERA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INTESTINE TRANSPLANTATION; INTIMA; MALE; NONHUMAN; PLAQUE FORMING CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SEROLOGY;

EID: 0037087697     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200203150-00005     Document Type: Article

References (53)

1. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
2. Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat
3. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts
4. Cardiac allograft vasculopathy: Current concepts, recent developments and future directions
5. Transplant coronary disease
6. Histopathology of graft coronary disease
7. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis
8. A rat small bowel transplant model of chronic rejection: Histopathologic characteristics
9. Cytomegalovirus
10. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation
11. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts
12. CMV causes bile duct destruction and arterial lesions in rat liver allografts
13. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression
14. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection
15. Cytomegaovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat
16. Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts
17. Cytomegalovirus infection and vessel wall pathology
18. Cytomegalovirus induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells
19. Direct induction of class II molecules by cytomegalovirus in rat heart microvascular endothelial cells is inhibited by ganciclovir (DHPG)
20. Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta
21. The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes
22. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression
23. Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft
24. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta I in rat aortic allografts: Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis
25. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells
26. Reactivation of human cytomegalovirus in a novel dendritic cell phenotype from healthy donors
27. IFN-γ and TNF-α specifically induce the formation of cytomegalovirus permissive monocyte-derived macrophages which are refractory to the antiviral activity of these cytokines
28. Cytokines and growth factors in atherogenesis
29. Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
30. Intestinal transplantation: Experience in the United States
31. Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection
32. Improved technique of heart transplantation in rats
33. Experimental graft arteriosclerosis. 1. The Lewis to F344 allograft model
34. Rat cytomegalovirus: Induction of and sensitivity to interferon
35. Biology of rat cytomegalovirus infection
36. Plaque assay of CMV strains of human origin
37. Characterization of RT6-bearing rat lymphocytes. II. Developmental relationships of RT6- and RT6+ T cells
38. Morphometric analysis of neointimal formation in murine cardiac allografts
39. Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts
40. Time-related effects of cytomegalovirus infection on the development of chronic renal allograft rejection in a rat model
41. Cytomegalovirus infection enhances the neointima formation in rat aortic allografts
42. Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta
43. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation
44. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant vascular atherosclerosis: A post hoc analysis of a randomized, placebo-controlled study
45. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection
46. Human cytomegalovirus IE1 and IE2 proteins block apoptosis
47. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor
48. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts
49. Vascular smooth muscle cell migration is induced by the human cytomegalovirus chemokine receptor US28
50. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host
51. Complete DNA sequence of the rat cytomegalovirus genome
52. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)
53. Bone marrow chimerism and transplantation tolerance